In the race to develop medication, test kits and vaccines aimed at COVID-19, Eternal Materials Co (長興材料), a company known for its chemical exports, has emerged as a dark horse.
Its rapid test kit for COVID-19 antibodies was one of the first to be manufactured in Taiwan, and it was used to test people linked to the largest cluster infection of COVID-19 seen in the country back in April.
Eternal Materials has now received formal approval to sell the product in Taiwan, as well as in the EU and several Southeast Asian countries, and it is applying for a permit in the US, company spokesman Liu Bing-cheng (劉秉誠) said.
Photo: CNA
“Without our previous experience, we wouldn’t have had this opportunity,” chief operating officer Mao Hui-kuan (毛惠寬) said in a recent interview, referring to seven rocky years endured by Eternal Materials’ biomedical research team.
Founded in 1964, the company is one of the largest suppliers of synthetic resins and photoresist materials in Asia. It ventured into the biomedical field in 2013, with a focus on test kits.
Although some of its products have proved useful in disease prevention, such as a test kit for dengue fever that the company worked on with the Centers for Disease Control (CDC), none of them have been a commercial success.
Photo: CNA
“We’ve struggled a lot,” to the point where management has considered dismantling the department, Mao said.
Yet the team persevered, and the pandemic, despite its adverse impact on the company’s business earlier this year, proved to be an opportunity for its research and development staff to put their expertise to good use.
In March, the CDC contacted Eternal Materials to see if it could develop a rapid test for detecting COVID-19 antibodies. Within 10 days, it had a prototype ready to go.
“We just kept trying and trying and trying,” Eternal Materials chief researcher Wang Hsi-kai (王璽凱) said.
The prototype was just the beginning; researchers at Eternal Materials continued to revise and improve the test kit over the following months.
It was used by the Central Epidemic Command Center in late April to test for antibodies when a cluster infection linked to a navy flotilla emerged.
Five months after the development process officially began, the team settled on a finalized version of the kit and called it the Eternal COVIDual COVID-19 IgM/IgG Rapid Test.
That same month, it became the third COVID-19 antibody test in Taiwan to receive emergency use authorization from the Food and Drug Administration.
Results can be seen in 15 minutes, and can indicate whether a person was infected recently or in the more distant past, with an accuracy rate of 98 percent, the company said.
However, other countries started manufacturing antibody rapid test kits months ago, raising questions whether Taiwan might be too late to the game to have an impact in the global market.
Chen Wen-ching (陳玟瑾), a manager in the company’s development department, acknowledges the challenges of being a late entrant, but sees other factors at play, especially quality and reliability.
The market was awash with test kits from China in April and May, but Taiwanese products are popular globally and quality remains the deciding factor whether a product is bought, she said.
“Even though we are a bit late, our products are good,” she said.
The company has already begun selling the test kits in small quantities overseas as it scales up production, hoping to increase its monthly output to 1 million kits by the end of the year, Chen said.
The goal is to produce 3 million test kits a month by March next year, and 11 million per month by the end of next year, she said.
That timetable suggests it might be a while before profits start to roll in, but Mao is not worried.
“It’s still exciting to be able to contribute to society, and be a part of the ‘national team’ that is fighting the disease,” he said.
PROTECTIONISM: China hopes to help domestic chipmakers gain more market share while preparing local tech companies for the possibility of more US sanctions Beijing is stepping up pressure on Chinese companies to buy locally produced artificial intelligence (AI) chips instead of Nvidia Corp products, part of the nation’s effort to expand its semiconductor industry and counter US sanctions. Chinese regulators have been discouraging companies from purchasing Nvidia’s H20 chips, which are used to develop and run AI models, sources familiar with the matter said. The policy has taken the form of guidance rather than an outright ban, as Beijing wants to avoid handicapping its own AI start-ups and escalating tensions with the US, said the sources, who asked not to be identified because the
FALLING BEHIND: Samsung shares have declined more than 20 percent this year, as the world’s largest chipmaker struggles in key markets and plays catch-up to rival SK Hynix Samsung Electronics Co is laying off workers in Southeast Asia, Australia and New Zealand as part of a plan to reduce its global headcount by thousands of jobs, sources familiar with the situation said. The layoffs could affect about 10 percent of its workforces in those markets, although the numbers for each subsidiary might vary, said one of the sources, who asked not to be named because the matter is private. Job cuts are planned for other overseas subsidiaries and could reach 10 percent in certain markets, the source said. The South Korean company has about 147,000 in staff overseas, more than half
Taipei is today suspending its US$2.5 trillion stock market as Super Typhoon Krathon approaches Taiwan with strong winds and heavy rain. The nation is not conducting securities, currency or fixed-income trading, statements from its stock and currency exchanges said. Yesterday, schools and offices were closed in several cities and counties in southern and eastern Taiwan, including in the key industrial port city of Kaohsiung. Taiwan, which started canceling flights, ship sailings and some train services earlier this week, has wind and rain advisories in place for much of the island. It regularly experiences typhoons, and in July shut offices and schools as
CHEMICAL FIRE: 10 Indian employees were injured by smoke inhalation at a Tata Electronics plant in Tamil Nadu state that produces components for Apple Inc At least 10 people received medical treatment, with two hospitalized after a major fire on Saturday disrupted production at a key Tata Electronics Pvt Ltd plant in southern India that makes Apple Inc’s iPhone components. The fire occurred at the plant in the city of Hosur in Tamil Nadu state that makes some iPhone components. It broke out near another building inside the Tata complex, which was to begin producing complete iPhones in the coming months. The fire was contained to one building and has been extinguished fully, top district administrative official K.M. Sarayu said. No decision has been made on when
RSS